Collegium Pharmaceutical, Inc. (COLL)

Import this data to Google Sheets with:

=jivedata("COLL","financials")

Full statements spill as a table. For one cell: =jivedata("COLL","Revenue") or =jivedata("COLL","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Collegium Pharmaceutical, Inc.

COLL • CIK 0001267565

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$566,767	$631,449	$780,567	$808,208
Gross Profit	$326,169	$377,344	$463,257	$485,087
Operating Income (Loss)	$166,961	$169,895	$179,636	$157,438
InterestExpenseNonoperating	—	$73,974	$82,312	$76,440
Investment Income, Net	$15,615	$13,976	$11,289	$12,676
Gain (Loss) on Extinguishment of Debt	$-23,504	$-11,329	$-15,994	$-15,994
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$75,733	$98,568	$92,619	$77,680
Income Tax Expense (Benefit)	$27,578	$29,378	$29,749	$29,765
Net Income (Loss) Attributable to Parent	$48,155	$69,190	$62,870	$47,915
Weighted Average Number of Shares Outstanding, Basic	33,741,213	32,273,850	31,706,429	32,179,366
Weighted Average Number of Shares Outstanding, Diluted	41,788,125	40,424,180	39,701,693	32,693,555
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization	$94,838	$88,801	$95,418	$93,749
Amortization of Intangible Assets	—	—	$221,892	$229,372
Cost of Goods and Services Sold	$240,598	$254,105	$317,310	$323,121
Selling, General and Administrative Expense	$159,208	$210,363	$284,803	$327,687
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	—	$-2,914	$-1,182	$-38
Operating Expenses	$159,208	$207,449	$283,621	$327,649
Interest on Convertible Debt, Net of Tax	$5,889	$5,863	$6,007	$3,047
Net Income (Loss) Attributable to Parent, Diluted	$54,044	$75,053	$68,877	$50,962
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities	6,793,421	6,606,305	6,606,305	0

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$238,947	$70,565	$231,252	$129,467
Marketable Securities, Current	$71,601	$92,198	$155,427	$0
Property, Plant and Equipment, Net	$15,983	$14,329	$12,013	$10,653
Accounts Receivable, after Allowance for Credit Loss, Current	$179,525	$228,540	$211,328	$285,102
Operating Lease, Right-of-Use Asset	$6,029	$5,822	$4,187	$3,791
Inventory, Net	$32,332	$35,560	$40,912	$113,269
Intangible Assets, Net (Excluding Goodwill)	$421,708	$891,402	$669,510	$1,186,084
Prepaid Expense and Other Assets, Current	$15,195	$30,394	$32,642	$60,326
Restricted Cash, Noncurrent	—	$1,047	$1,056	$1,060
Restricted Cash, Current	—	$25,000	$19,850	$19,850
Deferred Income Tax Assets, Net	$26,259	$98,033	$112,539	$120,774
Assets, Current	$537,600	$482,257	$691,411	$608,014
Other Assets, Noncurrent	$825	$8,368	$20,193	$15,237
Goodwill	$133,857	$162,333	$145,925	$190,177
Assets	$1,143,308	$1,663,591	$1,656,834	$2,135,790
Loans Payable, Noncurrent	$221,713	$550,733	$542,112	$797,824
Convertible Notes Payable, Noncurrent	$262,125	$237,172	$238,213	$238,733
Operating Lease, Liability, Noncurrent	$6,124	$5,539	$4,132	$3,407
Contract with Customer, Liability, Noncurrent	—	$10,000	$9,111	$8,778
Business Combination, Contingent Consideration, Liability, Noncurrent	—	$1,182	$0	$22,956
Liabilities	$947,877	$1,434,749	$1,355,159	$1,823,881
Accounts Payable, Current	$8,692	$3,934	$10,659	$9,241
Accrued Liabilities, Current	$37,571	$72,124	$62,464	$71,250
Loans Payable, Current	$183,333	$64,583	$29,000	$55,000
Operating Lease, Liability, Current	$988	$1,271	$1,407	$1,561
Business Combination, Contingent Consideration, Liability, Current	—	$28,956	$17,565	$15,569
Contract with Customer, Liability, Current	—	—	$667	$667
Liabilities, Current	$457,915	$509,510	$440,028	$589,861
Preferred Stock, Value, Issued	—	—	$0	$0
Common Stock, Value, Issued	$38	$40	$41	$41
Additional Paid in Capital	$565,949	$590,251	$624,954	$636,062
Treasury Stock, Common, Value	$137,381	$197,505	$222,510	$222,510
Accumulated Other Comprehensive Income (Loss), Net of Tax	$14	$55	$319	$0
Retained Earnings (Accumulated Deficit)	$-233,189	$-163,999	$-101,129	$-101,684
Stockholders' Equity Attributable to Parent	$195,431	$228,842	$301,675	$311,909
Preferred Stock, Shares Authorized	5,000,000	5,000,000	5,000,000	5,000,000
Common Stock, Shares Authorized	100,000,000	100,000,000	100,000,000	100,000,000
Common Stock, Shares, Issued	38,192,441	39,646,749	40,736,330	41,527,032
Common Stock, Shares, Outstanding	31,868,549	31,440,155	31,707,608	32,498,310
Treasury Stock, Common, Shares	6,323,892	8,206,594	9,028,722	9,028,722
Debt Securities, Available-for-sale, Current	$76,330	$94,191	$155,427	$157,341
Inventory, Noncurrent	—	$7,946	$14,014	$8,054

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$48,155	$69,190	$62,870	$47,915
Net Cash Provided by (Used in) Operating Activities	$274,749	$204,980	$329,323	$329,922
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	$63,759	$-143,382	$155,546	$12,129
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$239,994	$96,612	$252,158	$424,620
Amortization of Intangible Assets	—	—	$221,892	$229,372
Payments to Acquire Businesses, Net of Cash Acquired	$572,069	—	$0	$655,403
Depreciation	$3,496	$3,856	$4,182	$4,231
Payments to Acquire Property, Plant, and Equipment	$461	$1,652	$1,740	$1,643
Deferred Income Tax Expense (Benefit)	$-2,153	$-26,814	$-25,657	$-30,327
Payments to Acquire Marketable Securities	$92,351	$111,171	$126,968	$104,567
Share-based Payment Arrangement, Noncash Expense	$27,136	$32,400	$41,906	$44,928
Proceeds from Sale and Maturity of Marketable Securities	$22,000	$92,602	$65,176	$68,174
Net Cash Provided by (Used in) Investing Activities	$-70,812	$-287,759	$-63,532	$-551,901
Gain (Loss) on Extinguishment of Debt	$-23,504	$-11,329	$-15,994	$-15,994
Amortization of Debt Issuance Costs and Discounts	$8,635	$6,016	$5,341	$4,520
Accretion (Amortization) of Discounts and Premiums, Investments	$1,235	$2,028	$1,072	$707
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	—	$-2,914	$-1,182	$-38
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised	$460	$827	$1,363	$1,804
Proceeds from Stock Options Exercised	$8,641	$10,246	$4,280	$3,295
Payment, Tax Withholding, Share-based Payment Arrangement	$8,361	$19,170	$12,846	$17,904
Payments for Repurchase of Common Stock	$75,000	$60,025	$25,104	$25,104
Repayments of Notes Payable	$162,500	$107,813	$635,558	$617,766
Proceeds from Lines of Credit	—	—	$565,175	$565,175
Payment for Contingent Consideration Liability, Financing Activities	—	—	$7,555	$0
Proceeds from Convertible Debt	$235,220	$235,220	$0	$0
Repayments of Convertible Debt	$138,638	$138,638	$0	$0
Repayments of Assumed Debt	—	$164,598	$0	$0
Net Cash Provided by (Used in) Financing Activities	$-140,178	$-60,603	$-110,245	$234,108
Cash and Cash Equivalents, at Carrying Value	$238,947	$70,565	$231,252	$403,708
Restricted Cash and Cash Equivalents, Noncurrent	$1,047	$26,047	$20,906	$20,912
Interest Paid, Excluding Capitalized Interest, Operating Activities	$73,256	$62,434	$68,760	$67,654
Income Taxes Paid, Net	$24,205	$52,090	$60,041	$65,242
Capital Expenditures Incurred but Not yet Paid	—	$185	$319	$703
Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction	—	—	$271	$346
Business Combination, Consideration Transferred, Liabilities Incurred	—	$28,956	$0	$12,154
Increase (Decrease) in Accounts Receivable	$-3,594	$4,414	$-17,204	$13,610
Increase (Decrease) in Inventories	$-14,169	$-13,927	$5,353	$5,191
Increase (Decrease) in Prepaid Expense and Other Assets	$-1,439	$14,070	$7,968	$-9,052
Increase (Decrease) in Accounts Payable	$5,061	$-11,278	$6,718	$-3,748
Increase (Decrease) in Accrued Liabilities	$628	$-39,530	$-9,495	$10,714
Increase (Decrease) in Contract with Customer, Liability	—	—	$-222	$-555

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("COLL","financials")

Full statements spill as a table. For one cell: =jivedata("COLL","Revenue") or =jivedata("COLL","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.